Clinical Trial Update: Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia [Phase 3]

View source ↗

Summary

This document reports the results of a long-term safety Phase 3 study of lurasidone in clinically stable schizophrenia and schizoaffective disorder; results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Latuda (lurasidone)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 3 | Status: COMPLETED | Results posted: 2011-10-06